https://www.selleckchem.com/pr....oducts/i-brd9-gsk602
3 months, P .001). Survival probabilities for PTX (n= 294) were better than non-PTX (n= 47) (hazard ratio, 0.31; 95% CI 0.14-0.67; P .01) in SHPT patients (serum intact parathyroid hormone 500.0 pg/mL). CKD5 patients displayed a nondipping HR pattern, which is a prognostic marker of all-cause mortality. PTX for SHPT patients was associated with a reversal in nondipping HR ratio, which may mediate a better outcome. CKD5 patients displayed a nondipping HR pattern, which is a prognostic marker of all-cause mortality. PTX
Aimer
Commentaire
Partagez
